Related Experiment Video

Updated: May 25, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Update on cancer related issues of mesenchymal stem cell-based therapies

Dechun Wang1, Shuguang Wang, Chunmeng Shi

  • 1Institute of Combined Injury, State Key Laboratory of Trauma, Burns and Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, Chongqing, China.

Current Stem Cell Research & Therapy
|February 15, 2012
PubMed

Insights

Mesenchymal stem cells (MSCs) show promise in therapy but carry risks. Further research is needed to understand their complex role in cancer and long-term safety.

Area of Science:

  • Stem cell biology
  • Cancer research
  • Regenerative medicine

Background:

  • Mesenchymal stem cells (MSCs) are investigated for therapeutic potential.
  • Concerns exist regarding MSCs' tumorigenic risks and pro-tumorigenic activities.
  • MSCs can migrate to tumors, promoting proliferation, invasion, and metastasis.

Purpose of the Study:

  • To explore the dual role of MSCs in cancer.
  • To evaluate MSCs as targets for anti-tumor therapies.
  • To assess the long-term risks and benefits of MSCs in cancer treatment.

Main Methods:

  • Literature review on MSC behavior in cancer.
  • Analysis of studies on MSC migration and tumor modulation.
  • Evaluation of MSCs in gene/cell-mediated anti-tumor strategies.

Main Results:

  • MSCs exhibit complex interactions with tumors, with both risks and therapeutic potential.
  • Evidence suggests MSCs can promote tumor progression.
  • MSCs are also explored as vehicles for anti-cancer therapies.

Conclusions:

  • The application of MSCs in therapy requires careful consideration of their oncogenic potential.
  • Further investigation is crucial to balance MSC benefits against cancer risks.
  • Understanding MSCs' behavior in various pathological conditions is essential for safe application.

More Related Videos

Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells05:10

Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells

Published on: July 11, 2025

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions09:30

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions

Published on: January 7, 2019

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...